Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
- Update frequency
- every 5 days
- Episodes
- 347
- Years Active
- 2015 - 2025
Key Insights on Screening for HPV-Positive Oropharynx Cancer
Guest: Eleni Rettig, MD
HPV is the leading cause of oropharynx cancers in the United States, but with no screening tools currently available, how we can detect thi…
Exploring Fungi in Cancer-Type Tumors & Cancer Therapeutics
Guest: Gregory Sepich-Poore, MD/PhD
Results from a recent study detail the impact that fungi can have in human cancer tumors. What do we need to know…
Exploring Fungi in Cancer-Type Tumors & Cancer Therapeutics
Guest: Gregory Sepich-Poore, MD/PhD
Results from a recent study detail the impact that fungi can have in human cancer tumors. What do we need to know…
Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial
Guest: Hope S. Rugo, MD, FASCO
Results from the TROPiCS-02 trial may impact survival for patients with receptor–positive/HER2-negative breast cancer. To …
Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial
Guest: Hope S. Rugo, MD, FASCO
Results from the TROPiCS-02 trial may impact survival for patients with receptor–positive/HER2-negative breast cancer. To …
Recognizing the Role of Capmatinib for METex14 in NSCLC
Guest: Edward B. Garon, MD, MS
Recently approved capmatinib may be a new treatment for patients with metastatic non-small cell lung cancer who have MET exon 14 ski…
Recognizing the Role of Capmatinib for METex14 in NSCLC
Guest: Edward B. Garon, MD, MS
Recently approved capmatinib may be a new treatment for patients with metastatic non-small cell lung cancer who have MET exon 14 ski…
Evaluating Landmark Clinical Data for HER2-low Breast Cancer
Guest: Prof. David Cameron
A groundbreaking clinical study on patients with HER2-low breast cancer may impact they way we provide treatment. Dr. David Ca…
Evaluating Landmark Clinical Data for HER2-low Breast Cancer
Guest: Prof. David Cameron
A groundbreaking clinical study on patients with HER2-low breast cancer may impact they way we provide treatment. Dr. David Ca…
Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
Guest: Erika Hamilton, MD
A new treatment option for breast cancer may alter the treatment landscape for patients with HER2-positive metastatic breast ca…
Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
Guest: Erika Hamilton, MD
A new treatment option for breast cancer may alter the treatment landscape for patients with HER2-positive metastatic breast ca…
Updates on Breast Cancer Treatment: Exploring CDK4/6 Inhibitors & Endocrine Therapy
Guest: Kevin Kalinsky MD, MS
CDK4/6 inhibitors have changed the treatment landscape for hormone receptor-positive/HER2-negative metastatic breast cancer.…
Updates on Breast Cancer Treatment: Exploring CDK4/6 Inhibitors & Endocrine Therapy
Guest: Kevin Kalinsky MD, MS
CDK4/6 inhibitors have changed the treatment landscape for hormone receptor-positive/HER2-negative metastatic breast cancer.…
The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
Guest: Nan Chen, MD
Immunotherapy is starting to make its way in breast cancer, especially triple-negative breast cancer. So how do we identify which of …
The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
Guest: Nan Chen, MD
Immunotherapy is starting to make its way in breast cancer, especially triple-negative breast cancer. So how do we identify which of …
Treating Metastatic Breast Cancer: Where Are We Now?
Guest: Seema A. Khan, MD
Dr. Pavani Chalasani meets with Dr. Seema Khan, a Professor of Surgery and Interim Co-Vice Chair of Research at Northwestern Fei…
Treating Metastatic Breast Cancer: Where Are We Now?
Guest: Seema A. Khan, MD
Dr. Pavani Chalasani meets with Dr. Seema Khan, a Professor of Surgery and Interim Co-Vice Chair of Research at Northwestern Fei…
Exploring Drug Shortages in the U.S.: What Do We Need to Know?
Guest: Maya Leiva, PharmD, BCOP
What causes drug shortages in the U.S.? Joining Dr. Jacob Sands to answer this question and dive in to what physicians and pharmaci…
Exploring Drug Shortages in the U.S.: What Do We Need to Know?
Guest: Maya Leiva, PharmD, BCOP
What causes drug shortages in the U.S.? Joining Dr. Jacob Sands to answer this question and dive in to what physicians and pharmaci…
Bridging the Gaps in Care: How to Improve Care for LGBTQ+ Patients
Guest: Maya Leiva, PharmD, BCOP
Recognizing bias and improving diversity is critical for patient outcomes, especially within the field of oncology. To explore how …